Innovation For The Next Great Industry
AmeriCann, Inc. is a national leader of sustainable cultivation and processing infrastructure for the medical and Adult-Use marijuana industry.
WORLD-CLASS CANNABIS FACILITIES
We have a multi-market growth strategy with a current portfolio of over 1,000,000 sq. ft. of sustainable cannabis production infrastructure in development. We are a reporting, publicly listed company with the US stock symbol: ACAN on the OTCQB marketplace.
AmeriCann designs, builds and owns efficient, state of the art cultivation and processing facilities for the production of cannabis.
REAL ESTATE SERVICES
AmeriCann utilizes a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations.
AmeriCann has been instrumental in winning cannabis licenses in competitive application processes throughout the country.
NATIONWIDE SUPPORT NETWORK
Over the years AmeriCann has developed a support network of industry and community leaders and small businesses that stretches nationwide.
We assist our Preferred Partners with the selection of infused products to provide patients and consumers with greater choice in the delivery of cannabis.
With a team of industry leaders, AmeriCann delivers an unmatched level of knowledge and experience to the cannabis industry.
% of AMERICANS THAT SUPPORT MEDICAL MARIJUANA
INFRASTRUCTURE NEEDED FOR ADULT-USE MARKET
STATES WITH APPROVED MEDICAL MARIJUANA REGULATIONS
MARIJUANA PROHIBITION COST STATE & FED PER YEAR
Our Flagship Project:
The Massachusetts Cannabis Center (MCC)
AmeriCann is developing projects throughout the country in regulated markets through the Preferred Partner Program. The facilities we are developing are designed with the principles of traditional horticulture and utilize a lean manufacturing perspective. A great example of which is our Massachusetts Cannabis Center, or ‘MCC’.
The MCC consists of a planned 1 Million square feet of growing space that is zoned for both Recreational and Medicinal cultivation.
The first phase of the MCC project, Building 1, is a 30,000 square foot cultivation and processing facility that is 100% leased for 15-years to AmeriCann’s JV Partner Bask, Inc. Operations commenced in February of 2020.
Upon completion, the MCC will be a state of the art facility situated in a market which does not currently have enough cultivation infrastructure to supply product demand. The MCC aims to enable Massachusetts licensed marijuana businesses to meet this demand via leased space at the facility. In addition, AmeriCann is securing licenses to own and operate cultivation and product manufacturing space at MCC.
This project is on track to set a new standard of excellence in the cannabis industry for innovation in energy efficiency, cost control, and production.
The secret to change is to focus all of your energy, not on fighting the old, but on building the new.
Relevant news about AmeriCann (press releases and articles) and news about the Adult-Use and medical marijuana industry (new regulations, new states, medical studies, etc)
AmeriCann Achieves All-time Record Monthly Revenue in April 2021
AmeriCann Reports Record Quarterly Revenue and Positive EBITDA Company Also Achieved All-time Record Monthly Revenue in April 2021 Increased Sales Growth Obtained from its Flagship…
AmeriCann Announces Record Breaking Quarterly Revenue
The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center Boston, MA – April 6, 2021 – AmeriCann,…